General Information of the Protein
Protein ID |
PT02059
|
||||
---|---|---|---|---|---|
Protein Name |
C-X-C chemokine receptor type 4
|
||||
Secondarily Protein Name |
FB22
Fusin
HM89
LCR1
Leukocyte-derived seven transmembrane domain receptor
Lipopolysaccharide-associated protein 3
NPYRL
Stromal cell-derived factor 1 receptor
|
||||
Gene Name |
CXCR4
|
||||
Sequence |
MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFLTGIVGNGLVILVMGYQKKLRSMTDKYRLHLSVADLLFVITLPFWAVDAVANWYFGNFLCKAVHVIYTVNLYSSVLILAFISLDRYLAIVHATNSQRPRKLLAEKVVYVGVWIPALLLTIPDFIFANVSEADDRYICDRFYPNDLWVVVFQFQHIMVGLILPGIVILSCYCIIISKLSHSKGHQKRKALKTTVILILAFFACWLPYYIGISIDSFILLEIIKQGCEFENTVHKWISITEALAFFHCCLNPILYAFLGAKFKTSAQHALTSVSRGSSLKILSKGKRGGHSSVSTESESSSFHSS
Show/Hide
|
||||
Organism |
Homo sapiens, Human
|
||||
Protein Classification |
Membrane receptor
>
Family A G protein-coupled receptor
>
Peptide receptor (family A GPCR)
>
Chemokine receptor
>
CXC chemokine receptor
|
||||
Function |
Receptor for the C-X-C chemokine CXCL12/SDF-1 that transduces a signal by increasing intracellular calcium ion levels and enhancing MAPK1/MAPK3 activation (PubMed:10452968, PubMed:28978524, PubMed:18799424, PubMed:24912431). Involved in the AKT signaling cascade (PubMed:24912431). Plays a role in regulation of cell migration, e.g. during wound healing (PubMed:28978524). Acts as a receptor for extracellular ubiquitin; leading to enhanced intracellular calcium ions and reduced cellular cAMP levels (PubMed:20228059). Binds bacterial lipopolysaccharide (LPS) et mediates LPS-induced inflammatory response, including TNF secretion by monocytes (PubMed:11276205). Involved in hematopoiesis and in cardiac ventricular septum formation. Also plays an essential role in vascularization of the gastrointestinal tract, probably by regulating vascular branching and/or remodeling processes in endothelial cells. Involved in cerebellar development. In the CNS, could mediate hippocampal-neuron survival (By similarity).
Show/Hide
|
||||
Uniprot ID |
Show/Hide
|
||||
HGNC ID | |||||
Subcellular Location |
Cell membrane
Cell junction
Early endosome
Late endosome
Lysosome
|
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000064 , Chem-1
Cell Line ID: CL000108 , CCRF-CEM
Cell Line ID: CL000670 , CF2.Th
Cell Line ID: CL000011 , CHO
Cell Line ID: CL000026 , CHO-K1
Cell Line ID: CL000025 , HEK-293T
Cell Line ID: CL000006 , HEK293
Cell Line ID: CL000017 , HeLa
Cell Line ID: CL000501 , HeLa-MAGI-CCR5
Cell Line ID: CL000149 , HOS
Cell Line ID: CL000571 , HPB-ALL
Cell Line ID: CL000007 , HT-29
Cell Line ID: CL000001 , Jurkat
Cell Line ID: CL000116 , MOLT-4
Cell Line ID: CL000247 , MT-4
Cell Line ID: CL000651 , Reh
Cell Line ID: CL000200 , SUP-T1
Cell Line ID: CL000040 , THP-1
Cell Line ID: CL000043 , U2OS
Cell Line ID: CL000570 , U87.CD4.CXCR4
Biochemical Assays
Clinical Information about the Protein
Target 1 ( C-X-C chemokine receptor type 4 (CXCR4) )
Target Type | Successful Target | ||||
---|---|---|---|---|---|
Disease | 5 Target-related Diseases | 5 | |||
1 | Non-hodgkin lymphoma [ICD-11: 2B33.5] | ||||
2 | Whim syndrome [ICD-11: 4A00.Y] | ||||
3 | Solid tumour/cancer [ICD-11: 2A00-2F9Z] | ||||
4 | Human immunodeficiency virus-1 infection [ICD-11: 1C62] | ||||
5 | Acute lymphoblastic leukaemia [ICD-11: 2A85] | ||||
Approved Drug(s) | 1 Approved Drug | 1 | |||
1 | Plerixafor | Approved | |||
Clinical Trial Drug(s) | 2 Clinical Trial Drugs | 2 | |||
1 | AMD-070 | Phase 3 | |||
2 | MSX-122 | Phase 1 | |||
Investigative Drug(s) | 2 Investigative Drugs | 2 | |||
1 | GSK-812397 | Investigative | |||
2 | TN-14003 | Investigative |
Similar Protein(s) and Bioactivity Statistics
90% Identity
Protein ID | Protein Name | Protein Organism | |
PT06053 | C-X-C chemokine receptor type 4 | Rattus norvegicus, Rat |
---|